Company Story
1996 - The Westaim Corporation was founded by Dr. Hassan Khosrowshahi, a Canadian entrepreneur and inventor.
1998 - Westaim acquired its first company, iFire Technologies Inc., a developer of advanced materials and technologies.
2000 - Westaim went public on the Toronto Stock Exchange (TSX) with an initial public offering (IPO) of CAD 10 million.
2002 - Westaim acquired a majority stake in Nucryst Pharmaceuticals Corp., a developer of novel antimicrobial coatings.
2004 - Westaim acquired a majority stake in IMRIS Inc., a developer of advanced magnetic resonance imaging (MRI) systems.
2007 - Westaim divested its interest in iFire Technologies Inc. to focus on its healthcare investments.
2010 - Westaim acquired a majority stake in Isometrica Inc., a developer of advanced orthopedic implants.
2014 - Westaim divested its interest in Nucryst Pharmaceuticals Corp. and IMRIS Inc. to focus on its remaining investments.
2017 - Westaim acquired a majority stake in Paradigm Consulting Group Inc., a provider of IT consulting services.
2020 - Westaim divested its interest in Isometrica Inc. and Paradigm Consulting Group Inc. to focus on its remaining investments.